Proto Script Pharmaceutical Corp.
PSCR · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $56 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $166 | $104 | $105 | $140 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $20 | $12 | $35 | $1 |
| Total Curr. Assets | $187 | $116 | $196 | $145 |
| Property Plant & Equip (Net) | $40 | $42 | $33 | $26 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $7 | $0 | $0 |
| Total NC Assets | $48 | $50 | $33 | $26 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $235 | $166 | $229 | $170 |
| Liabilities | – | – | – | – |
| Payables | $156 | $160 | $131 | $157 |
| Short-Term Debt | $373 | $238 | $69 | $51 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $601 | $461 | $357 | $0 |
| Other Curr. Liab. | $1,148 | $927 | $854 | $281 |
| Total Curr. Liab. | $1,676 | $1,324 | $1,055 | $490 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,676 | $1,324 | $1,055 | $490 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $0 |
| Common Stock | $49 | $49 | $49 | $344 |
| Retained Earnings | -$8,739 | -$8,455 | -$8,123 | -$7,617 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $7,246 | $7,246 | $7,246 | $6,953 |
| Total Equity | -$1,442 | -$1,158 | -$826 | -$320 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $235 | $166 | $229 | $170 |
| Net Debt | $373 | $238 | $13 | $48 |